"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about CYMBALTA
• Ask Community about CYMBALTA
• CYMBALTA Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

CYMBALTA Safety Questions, CYMBALTA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CYMBALTA. Our extensive database of CYMBALTA adverse events and CYMBALTA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CYMBALTA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

CYMBALTA Safety Reports

Total CYMBALTA reports: 2908.
CYMBALTA FDA safety alerts: 2005 .
Reported deaths: 152    Reported hospitalizations: 677.
Take CYMBALTA Side Effects Survey or Share Your CYMBALTA Story. CYMBALTA Usage.

Showing 1-75 of 2908 Next >

Physician from UNITED STATES reported CYMBALTA problem on Jan 16, 2007. Female patient, 35 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. CYMBALTA dosage: 60 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 16, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: UNK MG, UNK. During the same period patient was treated with LIPITOR. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 16, 2007. Female patient, 32 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: 60 MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 17, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: unknown. Patient recovered.

Physician from GERMANY reported CYMBALTA problem on Jan 19, 2007. Female patient, 29 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: lower limb fracture, pelvic fracture, suicide attempt. CYMBALTA dosage: 30 MG, EACH MORNING. During the same period patient was treated with TAVOR. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from GERMANY on Jan 19, 2007. Female patient, 30 years of age, weighting 132.3 lb, was diagnosed with depression, back pain, hypothyroidism and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: mixed hepatocellular-cholestatic injury. CYMBALTA dosage: 60 MG, 2/D. During the same period patient was treated with KATADOLON, THYRONAJOD. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Jan 18, 2007. Female patient, 55 years of age, was diagnosed with neuropathy and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: blood magnesium increased, hepatic enzyme increased, rash pruritic. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with LIPITOR, METFORMIN, ACTOS, AMARYL. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 19, 2007. Male patient, 55 years of age, was diagnosed with diabetic neuropathy and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with METHADONE. Patient recovered.

Physician from reported CYMBALTA problem on Jan 19, 2007. Male patient, 54 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. CYMBALTA dosage: 60 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2007. Female patient, 58 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: agoraphobia, anxiety, binge eating, crying, diarrhoea, fear, insomnia, malaise, mania. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with SEROQUEL, LAMICTAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Jan 19, 2007. Female patient, 70 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, coronary artery disease and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: speech disorder, unresponsive to stimuli. CYMBALTA dosage: 90 MG, DAILY (1/D). During the same period patient was treated with INSULIN, PLAVIX. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2007. Female patient, 77 years of age, was diagnosed with neuralgia, blood pressure and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alopecia, chromaturia, constipation, feeling abnormal. CYMBALTA dosage: 30 MG, DAILY (1/D). During the same period patient was treated with DILTIAZEM, NEURONTIN. Patient recovered.

Physician from GERMANY reported CYMBALTA problem on Jan 23, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: parkinsonism. CYMBALTA dosage: 120 MG, DAILY (1/D). During the same period patient was treated with QUILONIUM, DIPIPERON. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 22, 2007. Female patient, 62 years of age, was diagnosed with major depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: aggression, delusion. CYMBALTA dosage: 30 MG, UNK. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 23, 2007. Female patient was diagnosed with bipolar disorder and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: polydactyly. CYMBALTA dosage: 30 MG, DAILY (1/D). Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 23, 2007. Female patient, 69 years of age, weighting 140.3 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: renal impairment. CYMBALTA dosage: 90 MG, DAILY (1/D). During the same period patient was treated with AMOXICILLIN, ASPIRIN, LAMOTRIGINE, LEVOTHYROXINE, OMEPRAZOLE, PICOSULPHATE. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 23, 2007. Male patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: UNK MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 22, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: limb malformation. CYMBALTA dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 22, 2007. Female patient was diagnosed with major depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hepatitis, nausea. CYMBALTA dosage: 60 MG, DAILY (1/D). Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 22, 2007. Female patient was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, liver disorder, pancreatitis. CYMBALTA dosage: UNK MG, UNK. Patient was hospitalized. Patient recovered.

Physician from SWITZERLAND reported CYMBALTA problem on Jan 23, 2007. Female patient, 59 years of age, was diagnosed with depression, osteoporosis and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: nodal arrhythmia. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with ZYPREXA, LAMICTAL, REMERON, TILUR, MAGNESIUM DIASPORAL, VITAMIN D3, CALCIMAGON, FOSAMAX. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2007. Female patient, 66 years of age, weighting 159.0 lb, was diagnosed with hypercalcaemia, nausea and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, arthritis, blood calcium decreased, blood creatinine increased, blood urea increased, bone debridement, bone disorder, breast cancer recurrent, cardiomyopathy. CYMBALTA dosage: unknown. During the same period patient was treated with TYLENOL, ANALPRAM HC, LEXAPRO, ZOMETA, AREDIA, MARINOL. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 23, 2007. Male patient, 41 years of age, weighting 162.3 lb, was diagnosed with panic disorder and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, fall, speech disorder. CYMBALTA dosage: 30 MG, DAILY (1/D). During the same period patient was treated with ETHANOL. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2007. Male patient was diagnosed with neck pain and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: aphasia, atrial fibrillation, cerebrovascular accident, dysmorphism, monoplegia. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with OXYCODONE. Patient was hospitalized and became disabled. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 24, 2007. Male patient, 72 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness. CYMBALTA dosage: 60 MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 25, 2007. Male patient, 40 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: coma, overdose. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with AMITRIPTYLINE, DIAZEPAM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 25, 2007. Female patient, 35 years of age, was diagnosed with depression, anxiety disorder, insomnia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, rhabdomyolysis. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with LEXAPRO, TRAZODONE. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, 39 years of age, weighting 130.0 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, cerebrovascular accident, delusion, dysarthria, economic problem, insomnia, psychotic disorder, speech disorder. CYMBALTA dosage: 60 MG DAILY ONCE DAILY. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Feb 06, 2007. Male patient, weighting 240.0 lb, was diagnosed with back pain, depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, hypertension. CYMBALTA dosage: unknown. Patient recovered.

CYMBALTA problem was reported by a Physician from SPAIN on Jan 26, 2007. Male patient, 54 years of age, was diagnosed with depression, diabetes mellitus and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with INSULIN. Patient recovered.

Physician from reported CYMBALTA problem on Jan 29, 2007. Male patient, 74 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. CYMBALTA dosage: 60 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 08, 2007. Female patient, weighting 123.5 lb, was diagnosed with pain management and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatitis, pancreatitis. CYMBALTA dosage: 30 MG, DAILY (1/D). During the same period patient was treated with DURAGESIC, RITALIN, PERCOCET. Patient was hospitalized. Patient recovered.

Physician from SWEDEN reported CYMBALTA problem on Jan 30, 2007. Female patient, 34 years of age, was diagnosed with depression, insomnia, anxiety, alopecia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alopecia, blood prolactin increased, polycystic ovaries. CYMBALTA dosage: 30 MG, DAILY (1/D). During the same period patient was treated with ZOLPIDEM TARTRATE, ATARAX, CYPROTERONE. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 29, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: limb reduction defect. CYMBALTA dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 26, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: UNK MG, DAILY (1/D). Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 29, 2007. Female patient was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. CYMBALTA dosage: 30 MG, DAILY (1/D). During the same period patient was treated with HUMALOG, LANTUS, ARTHROTEC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 29, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. CYMBALTA dosage: unknown. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 29, 2007. Male patient, 55 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with CIPRAMIL. Patient died.

Physician from UNITED STATES reported CYMBALTA problem on Jan 30, 2007. Male patient, 45 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hypertension. CYMBALTA dosage: 60 MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 30, 2007. Female patient, 36 years of age, was diagnosed with pain and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with TORADOL. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 30, 2007. Female patient, 55 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hypertension. CYMBALTA dosage: 60 MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from BELGIUM on Jan 30, 2007. Female patient, 55 years of age, weighting 169.8 lb, was diagnosed with osteoporosis prophylaxis, depression, anxiety and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatitis. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with LOSEC, MIACALCIC, TRAZOLAN, AKTON, TEMESTA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Jan 30, 2007. Female patient, 59 years of age, weighting 179.0 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, nausea. CYMBALTA dosage: 30 MG, DAILY (1/D). Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED KINGDOM on Jan 31, 2007. Female patient, 69 years of age, weighting 140.3 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: renal impairment. CYMBALTA dosage: 90 MG, DAILY (1/D). During the same period patient was treated with AMOXICILLIN, ASPIRIN, LAMOTRIGINE, LEVOTHYROXINE, OMEPRAZOLE, PICOSULPHATE. Patient recovered.

Physician from GERMANY reported CYMBALTA problem on Feb 01, 2007. Female patient, 41 years of age, weighting 110.2 lb, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: coma, intentional overdose, suicide attempt. CYMBALTA dosage: 900 MG, UNK. During the same period patient was treated with ZOPICLON. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 31, 2007. Female patient, 50 years of age, was diagnosed with anxiety and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: syncope, ventricular extrasystoles, ventricular tachycardia. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with NADOLOL, ACYCLOVIR, VALTREX, CALCIUM AND ERGOCALCIFEROL, IBUPROFEN. Patient recovered.

Physician from UNITED KINGDOM reported CYMBALTA problem on Feb 02, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: limb reduction defect. CYMBALTA dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 31, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: UNK MG, UNK. During the same period patient was treated with LOVENOX, COUMADIN, VICODIN. Patient recovered.

Physician from GERMANY reported CYMBALTA problem on Jan 31, 2007. Female patient, 80 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: fall, femoral neck fracture, hyponatraemia, syncope. CYMBALTA dosage: 90 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 66 years of age, weighting 159.0 lb, was diagnosed with hypercalcaemia, nausea and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: arthritis, blood calcium decreased, blood creatinine increased, blood urea increased, bone debridement, bone disorder, cardiomyopathy, catheter related complication, catheter removal. CYMBALTA dosage: unknown. During the same period patient was treated with TYLENOL, ANALPRAM HC, LEXAPRO, ZOMETA, AREDIA, MARINOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Feb 05, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, blood pressure increased, diarrhoea, feeling abnormal, malaise, nausea, serotonin syndrome. CYMBALTA dosage: 30 MG, UNK. During the same period patient was treated with WELLBUTRIN, VITAMINS, MINERALS NOS, PROGESTERONE. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 02, 2007. Female patient was diagnosed with pain and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chromaturia, dizziness, fatigue, haematochezia, heart rate increased, nausea, pruritus, rash. CYMBALTA dosage: 20 MG, UNK. Patient recovered.

Physician from UNITED KINGDOM reported CYMBALTA problem on Feb 05, 2007. Male patient, 65 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. CYMBALTA dosage: 90 MG, UNK. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 05, 2007. Male patient, 35 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. CYMBALTA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Feb 05, 2007. Female patient, 60 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hypertension, liver function test abnormal. CYMBALTA dosage: unknown. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 05, 2007. Female patient, 27 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, pain. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with SEROQUEL. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Feb 05, 2007. Female patient, 39 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: overdose. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with AMBIEN, LODRANE. Patient died on 01/01/2007.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 14, 2007. Male patient, 49 years of age, weighting 185.0 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: migraine. CYMBALTA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported CYMBALTA problem on Feb 06, 2007. Female patient, 66 years of age, weighting 224.0 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with LIPITOR, TOPROL, LOTREL, PROZAC. Patient recovered.

CYMBALTA problem was reported by a Physician from on Feb 06, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: coagulopathy, gastric bypass. CYMBALTA dosage: 90 MG, UNK. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Feb 06, 2007. Female patient, 16 years of age, was diagnosed with panic disorder and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, crying, physical assault. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with SEROQUEL, KLONOPIN. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from on Feb 06, 2007. Female patient, 50 years of age, weighting 99.98 lb, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, hypothyroidism, lethargy, major depression, migraine, suicidal ideation, suicide attempt. CYMBALTA dosage: 60 MG, UNK. Patient was hospitalized. Patient recovered.

Physician from BELGIUM reported CYMBALTA problem on Feb 06, 2007. Female patient, 55 years of age, weighting 169.8 lb, was diagnosed with depression, osteoporosis prophylaxis, anxiety and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatitis. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with LOSEC, MIACALCIC, TRAZOLAN, AKTON, TEMESTA. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 07, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with ZOCOR. Patient recovered.

Physician from SWEDEN reported CYMBALTA problem on Feb 07, 2007. Female patient, 21 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: anxiety, suicidal ideation, thrombocytopenia. CYMBALTA dosage: 30 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from GERMANY on Feb 06, 2007. Male patient, 50 years of age, was diagnosed with diabetic neuropathy and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: renal failure, somnolence. CYMBALTA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with DIURETICS, FENTANYL. Patient recovered.

Physician from SOUTH AFRICA reported CYMBALTA problem on Feb 07, 2007. Female patient, 52 years of age, was diagnosed with major depression, epilepsy and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: coma. CYMBALTA dosage: UNK MG, DAILY (1/D). During the same period patient was treated with EPILIM, XANOR. Patient was hospitalized. Patient recovered.

CYMBALTA problem was reported by a Physician from on Feb 12, 2007. Female patient, 36 years of age, was diagnosed with bipolar disorder, back pain and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: diplopia, hepatitis acute. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with LITHIUM CARBONATE, CLONAZEPAM, METHADONE, LORTAB. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported CYMBALTA problem on Feb 16, 2007. Male patient, weighting 180.8 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, insomnia, mental status changes, thinking abnormal. CYMBALTA dosage: 30 MG QAM PO. During the same period patient was treated with MIRTAZAPINE, TYLENOL, BENADRYL, DISULFIRAM. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 08, 2007. Female patient, 59 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hypertension. CYMBALTA dosage: 90 MG, DAILY (1/D). Patient recovered.

Consumer or non-health professional from SWEDEN reported CYMBALTA problem on Feb 08, 2007. Female patient, 65 years of age, was diagnosed with depression, asthma and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: asthma, liver function test abnormal, pain. CYMBALTA dosage: 30 MG, 2/D. During the same period patient was treated with VENTOLIN, BECOTIDE, OMEPRAZOLE. Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 08, 2007. Female patient was diagnosed with eating disorder and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. CYMBALTA dosage: 90 MG, UNK. Patient recovered.

Physician from SPAIN reported CYMBALTA problem on Feb 08, 2007. Female patient, 62 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. CYMBALTA dosage: 60 MG, DAILY (1/D). Patient recovered.

CYMBALTA problem was reported by a Physician from UNITED STATES on Feb 08, 2007. Female patient, 57 years of age, was diagnosed with major depression, rosacea and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: dizziness, hepatitis. CYMBALTA dosage: 60 MG, EACH MORNING. During the same period patient was treated with TETRACYCLINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Feb 08, 2007. Male patient, 40 years of age, weighting 213.0 lb, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: lethargy, somnolence. CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with KLONOPIN, TRAZODIL, SEROQUEL, AVINZA, VISTARIL, LAMISIL, UROXATRAL. Patient died on 11/05/2006.

Showing 1-75 of 2908 Next >

Ask Our Patient Community about CYMBALTA
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol